Home / Share Price Target / Medicameq
Medicamen Biotech Share Price Target 2024, 2025, 2026 to 2039 With Charts
Medicamen Biotech Limited | |||
 | Symbol: MEDICAMEQ | ||
| Price: ₹431.39 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Medicamen Biotech Brief Company Overview
- 1.1: Medicamen Biotech Limited: A Pharmaceutical Powerhouse
- 1.2: Medicamen Biotech Financial Performance
- 1.2.1: Is Medicamen Biotech A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Medicamen Biotech Share Price Target For 2024
- 2.1.1: Medicamen Biotech Share Price Target Table For 2024
- 2.1.2: Summary: Medicamen Biotech Share Price Prediction For 2024
- 2.2: Medicamen Biotech Share Price Target For 2025
- 2.2.1: Medicamen Biotech Share Price Target Table For 2025
- 2.2.2: Summary: Medicamen Biotech Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Medicamen Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Medicamen Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Medicamen Biotech Past Performance
Medicamen Biotech Brief Company Overview
Medicamen Biotech Limited: A Pharmaceutical Powerhouse
Medicamen Biotech Limited, established in 1993, is a leading pharmaceutical company headquartered in India.
Diverse Product Range: Medicamen Biotech offers an extensive range of products, including tablets, capsules, liquid and dry syrups, ointments, and creams across various therapeutic areas.
Industry Reputation: With over 27 years of experience, the company has earned a reputable reputation in the pharmaceutical industry for its quality products and commitment to innovation.
Commitment to Healthcare: Medicamen Biotech is dedicated to providing affordable and accessible healthcare solutions to patients in India and beyond.
Medicamen Biotech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 645.26 Crore | Market valuation of Medicamen Biotech's shares. |
| Revenue (TTM) | 180.41 Crore | Total revenue generated by Medicamen Biotech over the past twelve months. |
| Net Income (TTM) | +8.1 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 3.89% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 4.49% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +2.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -67.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 15.37 | Company's total debt divided by total shareholder equity. |
| Total Debt | 30.81 Crore | Sum of Medicamen Biotech's current & long-term financial obligations. |
| Total Cash | 14.78 Crore | Total amount of liquid funds available to Medicamen Biotech. |
| Beta | 1.5 | Beta is greater than 1 indicating that the Medicamen Biotech's price is more volatile than the market. |
Is Medicamen Biotech A Good Buy For Long Term?
No valid response content found
To predict the Medicamen Biotech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Medicamen Biotech Share Price Target For 2024
The line chart displays the monthly closing prices of Medicamen Biotech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medicamen Biotech shares in 2024, see the table below.
Medicamen Biotech Share Price Target Table For 2024
| Medicamen Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 450.10 (+4.33%) | Price Action: Mar 2017 Low |
| 2024 Target 2 | 444.95 (+3.14%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 438.64 (+1.68%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 431.39 | Medicamen Biotech's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 430.33 (-0.25%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 2 | 425.00 (-1.49%) | Price Action: Jan 2021 Low |
| Stop Loss 3 | 420.44 (-2.54%) | Fibonacci Retracement Extended 40% |
Summary: Medicamen Biotech Share Price Prediction For 2024
In summary, Medicamen Biotech has declined by ₹-171.76, recording a notable -28.48% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Medicamen Biotech for 2024 predicts an additional rise of 1.68% to 4.33% by the end of 2024 with three potential targets T1: 438.64, T2: 444.95, T3: 450.10. Stop Loss at SL1: 430.33, SL2: 425.00, SL3: 420.44.
Medicamen Biotech has a 52-week high of ₹657.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹355.45, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Medicamen Biotech.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Medicamen Biotech Share Price Target For 2025
The line chart displays the monthly closing prices of Medicamen Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Medicamen Biotech shares in 2025, see the table below.
Medicamen Biotech Share Price Target Table For 2025
| Medicamen Biotech's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 668.80 (+55.03%) | Price Action: Chart |
| 2025 Target 2 | 656.33 (+52.14%) | Price Action: Chart |
| 2025 Target 1 | 649.83 (+50.63%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 431.39 | Medicamen Biotech's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 380.05 (-11.91%) | Price Action: Oct 2020 Low |
| Stop Loss 2 | 376.00 (-12.84%) | Price Action: Sep 2020 Low |
| Stop Loss 3 | 370.00 (-14.24%) | Price Action: Jan 2017 High |
Summary: Medicamen Biotech Share Price Prediction For 2025
In summary, Medicamen Biotech has declined by ₹-171.76, recording a notable -28.48% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Medicamen Biotech for 2025 predicts an additional rise of 50.63% to 55.03% by the end of 2025 with three potential targets T1: 649.83, T2: 656.33, T3: 668.80. Stop Loss at SL1: 380.05, SL2: 376.00, SL3: 370.00.
Medicamen Biotech has a All-Time high of ₹1225.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹355.45, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Medicamen Biotech, we have created a specific page for that check here: Medicamen Biotech Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Medicamen Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Medicamen Biotech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 4.14% over the next 15 years.
For complete year by year Medicamen Biotech long term share price target from 2024, 2025 to 2039 check the below table.
Medicamen Biotech Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Medicamen Biotech Target | YoY Change % |
|---|---|---|
| 2024 | ₹431.39 | [Current Price] |
| 2024 | ₹459.3 | 6.46% |
| 2025 | ₹344.16 | -25.07% |
| 2026 | ₹390.97 | 13.6% |
| 2027 | ₹367.22 | -6.08% |
| 2028 | ₹313.05 | -14.76% |
| 2029 | ₹349.91 | 11.77% |
| 2030 | ₹315.6 | -9.81% |
| 2031 | ₹671.9 | 112.89% |
| 2032 | ₹739.67 | 10.08% |
| 2033 | ₹642.62 | -13.13% |
| 2034 | ₹733.58 | 14.15% |
| 2035 | ₹751.87 | 2.49% |
| 2036 | ₹786.13 | 4.55% |
| 2037 | ₹861.29 | 9.56% |
| 2038 | ₹744.91 | -13.52% |
| 2039 | ₹810.31 | 8.77% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Medicamen Biotech Past Performance
- In 2006, Medicamen Biotech opening price was ₹12.25
- As of Thu 21 Nov 2024 the price stands at ₹431.39.
- This represents a Compound Annual Growth Rate (CAGR) of 20.62%.
- In 18 years, an investment of 10,000 would have become ₹3.52 Lakh.
As we wrap up, we hope you like our study on Medicamen Biotech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Medicamen Biotech Share Price History
- Medicamen Biotech Price Target Tomorrow
- Medicamen Biotech Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
